Clinical parameters predictive of outcomes in sorafenib‐treated patients with advanced hepatocellular carcinoma

Abstract

Advanced HCC patients treated with sorafenib who experienced hand-foot syndrome and diarrhoea showed better overall survival than patients without these side effects. These side effects may be used as clinical parameters predictive of sorafenib response in patients with HCC.